Jefferies Group LLC Verastem, Inc. Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	BUY	$1.26 - $3.38 $13,230 - $35,490	10,500 New	10,500 $28,000
Q1 2019 May 15, 2019	SELL	$2.79 - $4.09 $35,977 - $52,740	-12,895 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.23 - $7.01 $6,120 - $13,283	1,895 Added 17.23%	12,895 $43,000
Q3 2018 Nov 14, 2018	BUY	$6.86 - $9.97 $75,460 - $109,670	11,000 New	11,000 $80,000
Q2 2018 Aug 14, 2018	SELL	$2.88 - $8.67 $87,264 - $262,701	-30,300 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.92 - $3.81 $88,476 - $115,443	30,300 New	30,300 $90,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.2B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.